Joint United Nations Programme on HIV/AIDS. AIDSinfo, Global data on HIV epidemiology and response. https://aidsinfo.unaids.org. Accessed 2 July 2024.

Zhang J, Ma B, Han X, Ding S, Li Y. Global, regional, and national burdens of HIV and other sexually transmitted infections in adolescents and young adults aged 10–24 years from 1990 to 2019: a trend analysis based on the Global Burden of Disease Study 2019. Lancet Child Adolesc Health. 2022;6(11):763–76. https://doi.org/10.1016/S2352-4642(22)00219-X.

Article  PubMed  Google Scholar 

Becker M, Mishra S, Bhattacharjee P, et al. Differential burden of HIV among adolescent girls and young women by places associated with sex work: an observational study in Mombasa, Kenya. J Acquir Immune Defic Syndr. 2024;96(2):121–9. https://doi.org/10.1097/QAI.0000000000003412.

Article  PubMed  Google Scholar 

Torres TS, Teixeira SLM, Hoagland B, et al. Recent HIV infection and annualized HIV incidence rates among sexual and gender minorities in Brazil and Peru (ImPrEP seroincidence study): a cross-sectional, multicenter study. Lancet Reg Health Am. 2023;28: 100642. https://doi.org/10.1016/j.lana.2023.100642.

Article  PubMed  PubMed Central  Google Scholar 

United Nations Children’s Fund. Adolescent HIV treatment. https://data.unicef.org/topic/hivaids/adolescent-hiv-treatment. Accessed 2 July 2024.

National Institute of Allergy and Infectious Diseases (NIAID). Phase I/II study of the safety, acceptability, tolerability, and pharmacokinetics of oral and long-acting injectable cabotegravir and long-acting injectable rilpivirine in virologically suppressed HIV-infected children and adolescents. ClinicalTrials.gov identifier: NCT03497676. 2023. https://clinicaltrials.gov/study/NCT03497676. Accessed 2 July 2024.

Landovitz RJ, Donnell D, Clement ME, et al. Cabotegravir for HIV prevention in cisgender men and transgender women. N Engl J Med. 2021;385(7):595–608. https://doi.org/10.1056/NEJMoa2101016.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Delany-Moretlwe S, Hughes JP, Bock P, et al. Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial. Lancet. 2022;399(10337):1779–89. https://doi.org/10.1016/S0140-6736(22)00538-4.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Adolescent Medicine Trials Network for HIV Interventions. ATN HIV. https://www.atnconnect.org/. Accessed 2 July 2024.

International Maternal Pediatric Adolescent AIDS Clinical Trials Network. IMPAACT network. https://www.niaid.nih.gov/research/impaact. Accessed 2 July 2024.

National Institute of Health Eunice Kennedy Shriver National Institute of Child Health and Human Development. Prevention and treatment through a comprehensive care continuum for HIV-affected adolescents in resource constrained settings (PATC3H). https://www.nichd.nih.gov/research/supported/PATC3H. Accessed 2 July 2024.

Culhane J, Sharma M, Wilson K, et al. Modeling the health impact and cost threshold of long-acting ART for adolescents and young adults in Kenya. EClinicalMedicine. 2020;25: 100453. https://doi.org/10.1016/j.eclinm.2020.100453.

Article  PubMed  PubMed Central  Google Scholar 

Phillips AN, Cambiano V, Johnson L, et al. Potential impact and cost-effectiveness of condomless-sex-concentrated PrEP in Kwazulu-Natal accounting for drug resistance. J Infect Dis. 2021;223(8):1345–55. https://doi.org/10.1093/infdis/jiz667.

Article  PubMed  Google Scholar 

Neilan AM, Bangs AC, Hudgens M, et al. Modeling adherence interventions among youth with HIV in the United States: clinical and economic projections. AIDS Behav. 2021;25(9):2973–84. https://doi.org/10.1007/s10461-021-03169-0.

Article  PubMed  PubMed Central  Google Scholar 

Kripke K, Chen PA, Vazzano A, et al. Cost and impact of voluntary medical male circumcision in South Africa: focusing the program on specific age groups and provinces. PLoS ONE. 2016;11(7): e0157071. https://doi.org/10.1371/journal.pone.0157071.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pitman R, Fisman D, Zaric GS, et al. Dynamic transmission modeling: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force—5. Value Health. 2012;15(6):828–34. https://doi.org/10.1016/j.jval.2012.06.011.

Article  PubMed  PubMed Central  Google Scholar 

Husereau D, Drummond M, Augustovski F, et al. Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations. Value Health. 2022;25(1):3–9. https://doi.org/10.1016/j.jval.2021.11.1351.

Article  PubMed  Google Scholar 

Avanceña ALV, Hutton DW. Optimization models for HIV/AIDS resource allocation: a systematic review. Value Health. 2020;23(11):1509–21. https://doi.org/10.1016/j.jval.2020.08.001.

Article  PubMed  Google Scholar 

Vasantharoopan A, Simms V, Chan Y, Guinness L, Maheswaran H. Modelling methods of economic evaluations of HIV testing strategies in sub-saharan Africa: a systematic review. Appl Health Econ Health Policy. 2023;21(4):585–601. https://doi.org/10.1007/s40258-022-00782-5.

Article  PubMed  Google Scholar 

Knight J, Kual R, Mishra S. Risk heterogeneity in compartmental HIV transmission models of ART as prevention in sub-Saharan Africa: a scoping review. Epidemics. 2022. https://doi.org/10.1016/j.epidem.2022.100608.

Article  PubMed  Google Scholar 

Huang YLA, Lasry A, Hutchinson AB, Sansom SL. A systematic review on cost effectiveness of HIV prevention interventions in the United States. Appl Health Econ Health Policy. 2015;13(2):149–56. https://doi.org/10.1007/s40258-014-0142-5.

Article  PubMed  Google Scholar 

Peters M, Godfrey C, Mclnerney P, Munn Z, Tricco A, Khalil H. JBI manual for evidence synthesis. https://jbi-global-wiki.refined.site/space/MANUAL/4687342/Chapter+11%3A+Scoping+reviews. Accessed 2 July 2024.

Tricco AC, Lillie E, Zarin W, et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169(7):467–73. https://doi.org/10.7326/M18-0850.

Article  PubMed  Google Scholar 

Tricco AC, Zarin W, Ghassemi M, et al. Same family, different species: methodological conduct and quality varies according to purpose for five types of knowledge synthesis. J Clin Epidemiol. 2018;96:133–42. https://doi.org/10.1016/j.jclinepi.2017.10.014.

Article  PubMed  Google Scholar 

Munn Z, Peters MDJ, Stern C, Tufanaru C, McArthur A, Aromataris E. Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach. BMC Med Res Methodol. 2018;18(1):143. https://doi.org/10.1186/s12874-018-0611-x.

Article  PubMed  PubMed Central  Google Scholar 

National Institute of Health Office of AIDS Research. Adult and adolescent ARV archive guidelines. https://clinicalinfo.hiv.gov/en/guidelines/archived-guidelines/adult-and-adolescent-guidelines. Accessed 2 July 2024.

Covidence systematic review software, Veritas Health Innovation, Melbourne, Australia. www.covidence.org.

World Health Organization. Adolescent and young adult health. https://www.who.int/news-room/fact-sheets/detail/adolescents-health-risks-and-solutions. Accessed 2 July 2024.

Aldridge RW, Iglesias D, Cáceres CF, Miranda JJ. Determining a cost effective intervention response to HIV/AIDS in Peru. BMC Public Health. 2009;9:352. https://doi.org/10.1186/1471-2458-9-352.

Article  PubMed  PubMed Central  Google Scholar 

Caro JJ, Briggs AH, Siebert U, Kuntz KM. ISPOR-SMDM Modeling Good Research Practices Task Force. Modeling good research practices—Overview: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-1. Med Decis Mak. 2012;32(5):667–77. https://doi.org/10.1177/0272989X12454577.

Article  Google Scholar 

Briggs AH, Weinstein MC, Fenwick EAL, et al. Model parameter estimation and uncertainty: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force—6. Value Health. 2012;15(6):835–42. https://doi.org/10.1016/j.jval.2012.04.014.

Article  PubMed  Google Scholar 

Eddy DM, Hollingworth W, Caro JJ, et al. Model transparency and validation: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-7. Med Decis Mak. 2012;32(5):733–43. https://doi.org/10.1177/0272989X12454579.

Article  Google Scholar 

Roberts M, Russell LB, Paltiel AD, et al. Conceptualizing a model: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-2. Med Decis Mak. 2012;32(5):678–89. https://doi.org/10.1177/0272989X12454941.

Article  Google Scholar 

The EndNote Team, Clarivate, Philadelphia. EndNote.

Siebert U, Alagoz O, Bayoumi AM, et al. State-transition modeling: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-3. Med Decis Mak. 2012;32(5):690–700. https://doi.org/10.1177/0272989X12455463.

Article  Google Scholar 

Kim SY, Goldie SJ. Cost-effectiveness analyses of vaccination programmes: a focused review of modelling approaches. Pharmacoeconomics. 2008;26(3):191–215. https://doi.org/10.2165/00019053-200826030-00004.

Article  PubMed  Google Scholar 

Zanoni BC, Archary M, Buchan S, Katz IT, Haberer JE. Systematic review and meta-analysis of the adolescent HIV continuum of care in South Africa: the cresting wave. BMJ Glob Health. 2016;1(3): e000004. https://doi.org/10.1136/bmjgh-2015-000004.

Article  PubMed  PubMed Central  Google Scholar 

Zanoni BC, Mayer KH. The adolescent and young adult HIV cascade of care in the United States: exaggerated health disparities. AIDS Patient Care STDS. 2014;28(3):128–35. https://doi.org/10.1089/apc.2013.0345.